Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tanacetum sinaicum essential oil is a botanical extract derived from the Sinai Tansy plant (*Tanacetum sinaicum*) through hydrodistillation. Characterized by high concentrations of chrysanthenyl acetate, thujone, and verbenol, the oil exhibits multi-faceted biological activities including antiviral, antiproliferative, and anti-metastatic effects. In preclinical in vitro models, it has demonstrated significant efficacy in inhibiting the replication of human papillomavirus (HPV) types 16 and 18 and suppressing the growth of HeLa (cervical cancer) and MCF-7 (breast adenocarcinoma) cell lines. The oil's mechanism of action involves the induction of autophagy and dose-dependent genotoxicity, leading to DNA damage and programmed cell death in malignant cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tanacetum sinaicum essential oil.